Save up -80% on Anidulafungin
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Eraxis
|price without discount in nearest pharmacy. Price may vary.|
We offer free Eraxis coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Anidulafungin every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Anidulafungin volume of distribution
The pharmacokinetics of anidulafungin are characterised by a rapid distribution half-life (0.5-1 hour) and a volume of distribution, 30-50 l, which is similar to total body fluid volume. Anidulafungin is extensively bound (> 99%) to human plasma proteins.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Anidulafungin
Anidulafungin or Eraxis is an anti-fungal drug manufactured by Pfizer that gained approval by the Food and Drug Administration (FDA) in February 21, 2006; it was previously known as LY303366. There is preliminary evidence that it has a similar safety profile to caspofungin. (Wikipedia)
Anidulafungin mechanism of action
Anidulafungin is a semi-synthetic echinocandin with antifungal activity. Anidulafungin inhibits glucan synthase, an enzyme present in fungal, but not mammalian cells. This results in inhibition of the formation of 1,3- beta;-D-glucan, an essential component of the fungal cell wall, ultimately leading to osmotic instability and cell death.
Dosage forms of Anidulafungin
|Injection, powder, lyophilized, for solution||intravenous||100 mg/30mL|
|Injection, powder, lyophilized, for solution||intravenous||50 mg/15mL|
|Powder for solution||intravenous||100 mg|
(4R,5R)-4,5-Dihydroxy-N-((4”-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6- 1)-peptide Anidulafungin
Pfizer Canada Inc
Candida albicans and other yeasts
Indication of Anidulafungin
For use in the treatment of the following fungal infections: Candidemia and other forms of i Candida /i infections (intra-abdominal abscess, and peritonitis), Aspergillus infections, and esophageal candidiasis. Also considered an alternative treatment for oropharyngeal canaidiasis.
Toxicity of Anidulafungin
During clinical trials a single 400 mg dose of anidulafungin was inadvertently administered as a loading dose. No clinical adverse events were reported. The maximum non-lethal dose of anidulafungin in rats was 50 mg/kg, a dose which is equivalent to 10 times the recommended daily dose for esophageal candidiasis (50mg/day).
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Anidulafungin on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.